FCF co-organized, along with its companion YAFO Capital, the “ACCESS CHINA Biotech Discussion board” which was held on-line on June 21st & 24th, 2022. ACCESS CHINA Biotech Discussion board...
FCF co-organizes, along with its accomplice YAFO Capital, the “ACCESS CHINA Biotech Discussion board” which will probably be held on-line on June 21st & 24th, 2022. ACCESS CHINA Biotech...
Enterprise capital deal volumes within the European life sciences sector reached a record-breaking stage in 2021. Nonetheless, financing volumes decreased considerably by 29% within the first 4 months of...
With 44 offers, the company enterprise arm of Boehringer Ingelheim was essentially the most energetic company investor within the European life science market within the final 5 years. The...
FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Life Sciences Enterprise Capital Monitor – Europe 04/2022”.The Monitor is a month-to-month printed overview of enterprise...
It’s no shock that the highest 5 European traders have proven considerably larger actions than US traders in Europe from 2017 to 2021.Nonetheless, US traders resembling SOSV, Epidarex Capital,...
FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Life Sciences Enterprise Capital Monitor – Europe 03/2022”. The Monitor is a month-to-month printed overview of...
FCF co-organizes, along with its associate YAFO Capital, the “ACCESS CHINA Biotech Discussion board” which shall be held on-line on April 18th & 19th, 2022. ACCESS CHINA Biotech Discussion...
FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Life Sciences Enterprise Capital Monitor – Europe 02/2022”. The Monitor is a month-to-month revealed overview of...
FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Life Sciences Enterprise Capital Monitor – Europe 01/2022”. The Monitor is a month-to-month printed overview of...